company background image
VIMTALABS logo

Vimta Labs NSEI:VIMTALABS Stock Report

Last Price

₹961.90

Market Cap

₹21.4b

7D

0.6%

1Y

140.9%

Updated

21 Dec, 2024

Data

Company Financials

Vimta Labs Limited

NSEI:VIMTALABS Stock Report

Market Cap: ₹21.4b

VIMTALABS Stock Overview

Provides contract research and testing services in India and internationally. More details

VIMTALABS fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends2/6

Rewards

Price-To-Earnings ratio (43.4x) is below the Life Sciences industry average (49.9x)

Earnings have grown 27.2% per year over the past 5 years

Risk Analysis

Significant insider selling over the past 3 months

Volatile share price over the past 3 months compared to the Indian market


My Notes

Capture your thoughts, links and company narrative

Vimta Labs Limited Competitors

Tarsons Products

NSEI:TARSONS

₹21.3b

Windlas Biotech

NSEI:WINDLAS

₹21.6b

Borosil Scientific

BSE:544184

₹15.1b

Innova Captab

NSEI:INNOVACAP

₹56.0b

Price History & Performance

Summary of share price highs, lows and changes for Vimta Labs
Historical stock prices
Current Share Price₹961.90
52 Week High₹1,069.95
52 Week Low₹399.70
Beta0.59
1 Month Change25.80%
3 Month Change70.66%
1 Year Change140.90%
3 Year Change142.08%
5 Year Change950.68%
Change since IPO5.88%

Recent News & Updates

Recent updates

Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

Nov 09
Subdued Growth No Barrier To Vimta Labs Limited (NSE:VIMTALABS) With Shares Advancing 28%

There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

Sep 06
There's Reason For Concern Over Vimta Labs Limited's (NSE:VIMTALABS) Massive 31% Price Jump

It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Jul 12
It Looks Like Shareholders Would Probably Approve Vimta Labs Limited's (NSE:VIMTALABS) CEO Compensation Package

Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Jun 12
Vimta Labs (NSE:VIMTALABS) Seems To Use Debt Quite Sensibly

Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

Apr 26
Market Might Still Lack Some Conviction On Vimta Labs Limited (NSE:VIMTALABS) Even After 26% Share Price Boost

It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

Jan 06
It's A Story Of Risk Vs Reward With Vimta Labs Limited (NSE:VIMTALABS)

If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Jul 14
If EPS Growth Is Important To You, Vimta Labs (NSE:VIMTALABS) Presents An Opportunity

Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00

Jun 03
Vimta Labs (NSE:VIMTALABS) Has Announced A Dividend Of ₹2.00

Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00

May 06
Vimta Labs' (NSE:VIMTALABS) Dividend Will Be ₹2.00

A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)

Dec 07
A Look At The Intrinsic Value Of Vimta Labs Limited (NSE:VIMTALABS)

Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Nov 06
Here's Why We Think Vimta Labs (NSE:VIMTALABS) Might Deserve Your Attention Today

Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Jun 02
Vimta Labs (NSE:VIMTALABS) Is Due To Pay A Dividend Of ₹2.00

Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Dec 06
Does Vimta Labs (NSE:VIMTALABS) Deserve A Spot On Your Watchlist?

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Oct 27
Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Jun 29
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Vimta Labs Limited's (NSE:VIMTALABS) CEO For Now

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Jun 19
Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Mar 09
Here's Why Vimta Labs (NSE:VIMTALABS) Can Manage Its Debt Responsibly

Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?

Jan 20
Vimta Labs Limited's (NSE:VIMTALABS) Stock Is Going Strong: Have Financials A Role To Play?

Did You Miss Vimta Labs' (NSE:VIMTALABS) 87% Share Price Gain?

Dec 30
Did You Miss Vimta Labs' (NSE:VIMTALABS) 87% Share Price Gain?

Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Dec 09
Does Vimta Labs (NSE:VIMTALABS) Have A Healthy Balance Sheet?

Here's What We Learned About The CEO Pay At Vimta Labs Limited (NSE:VIMTALABS)

Nov 17
Here's What We Learned About The CEO Pay At Vimta Labs Limited (NSE:VIMTALABS)

Shareholder Returns

VIMTALABSIN Life SciencesIN Market
7D0.6%-1.3%-4.2%
1Y140.9%49.7%19.1%

Return vs Industry: VIMTALABS exceeded the Indian Life Sciences industry which returned 49.7% over the past year.

Return vs Market: VIMTALABS exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is VIMTALABS's price volatile compared to industry and market?
VIMTALABS volatility
VIMTALABS Average Weekly Movement8.5%
Life Sciences Industry Average Movement6.2%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: VIMTALABS's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: VIMTALABS's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19841,428Harita Vasireddivimta.com

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, central lab, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; a testing laboratory for water, alcoholic, and non-alcoholic beverages; and clinical diagnostic services to patients, clinicians, hospitals, and central lab services to support clinical research studies.

Vimta Labs Limited Fundamentals Summary

How do Vimta Labs's earnings and revenue compare to its market cap?
VIMTALABS fundamental statistics
Market cap₹21.40b
Earnings (TTM)₹493.32m
Revenue (TTM)₹3.38b

43.4x

P/E Ratio

6.3x

P/S Ratio

Is VIMTALABS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VIMTALABS income statement (TTM)
Revenue₹3.38b
Cost of Revenue₹942.90m
Gross Profit₹2.43b
Other Expenses₹1.94b
Earnings₹493.32m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)22.21
Gross Margin72.07%
Net Profit Margin14.61%
Debt/Equity Ratio3.4%

How did VIMTALABS perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

11%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 20:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vimta Labs Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.
Vijay MadunalaFirstCall Research